Sanchez Ramiro
SEC insider (Form 3/4/5 filer). CIK 0001830326. Director at Rapport Therapeutics, Inc. (RAPP) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 23, 2026. Located in BOSTON, MA.
Companies Sanchez Ramiro has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Director
- Alto Neuroscience, Inc. (ANRO): Director
Sanchez Ramiro
CIK: 0001830326
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 23, 2026RAPP
Rapport Therapeutics, Inc.
PurchaseDirect3.6K shares at avg. $27.35$98K - Jun 10, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
15.2K shares- - May 12, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
11K shares- - Jan 2, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
3.8K shares at avg. $11.82- - Aug 12, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
30.6K shares- - Aug 12, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
3.9K shares at avg. $2.21- - Jun 17, 2025RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10.9K shares- - Nov 7, 2024RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
29.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 23, 2026 |  RAPP Rapport Therapeutics, Inc. | Purchase | 3,600 | $27.35 | $98,478 | Direct |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 15,200 | - | - | Direct |
| May 12, 2026 |  ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 10,958 | - | - | Direct |
| Jan 2, 2026 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 3,806 | $11.82 | - | Direct |
| Aug 12, 2025 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 30,574 | - | - | Direct |
| Aug 12, 2025 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 3,928 | $2.21 | - | Direct |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 10,925 | - | - | Direct |
| Nov 7, 2024 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 29,756 | - | - | Direct |
1-8 of 8 transactions